Emmune, Inc
Emmune, Inc. is a start-up biotechnology company that has a novel approach for treating and preventing HIV infection. We engineered a synthetic antibody from the receptors that HIV uses to infect T cells, CD4 and CCR5. Because this synthetic antibody, known as “eCD4-Ig,” is built from the viral receptor and co-receptor, it recognizes 100% of HIV-1 isolates. A single intramuscular inoculation with an AAV vector expressing eCD4-Ig protected monkeys from multiple intravenous challenges with live virus.
7-day free trial · no credit card
Verified contacts
3
available on Kipplo
LinkedIn employees
3
1 to 10 range
Open roles
—
no listings
Distinct roles
3
indexed titles
Tech stack
0
tools in use
Monthly traffic
30
organic / mo
Sign up free to see all 3 verified contacts at Emmune, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
3 contacts with verified email or phone · masked until revealed.
- YH
Youai Hao
Research Scientist · Research & Development
EmailPhone - MA
Michael Alpert
Founder · General Business & Management
EmailPhone
Showing 2 of 3 verified contacts
Top roles at Emmune, Inc
3 distinct titles indexed · top 3 shown.
- 1founder
- 1quality controller
- 1research scientist
Sign up to unlock all 3 contacts at Emmune, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 3 verified contacts at Emmune, Inc
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.